Key Highlights
- Shares closed at A$5.25 on 18 November 2026, down 2.05% on the day and up approximately 9.15% over one year.
- Resident policyholder numbers grew by 1.1%, according to the company's FY26 release.
- Almost A$300 million in value was delivered to customers through Members' Choice, no gap networks and Live Better rewards.
- Cumulative productivity savings reached A$132.4 million since the program began.
Medibank Private Limited (ASX:MPL) provides private Health Insurance in Australia through its Medibank and ahm brands, and operates health services through Medibank Health. Its shares closed at A$5.25 on 18 November 2026, down 2.05% for the session and up approximately 9.15% over the past year. The company released its FY26 full-year results on 20 August 2026.
Latest Update
On 20 August 2026, Medibank reported its full-year results, stating that it serves around 6 million people with their health and wellbeing. Resident policyholder growth was 1.1%, and the company said momentum improved in the Medibank brand, and ahm continued to grow above the market.
The company delivered almost A$300 million in value to customers through Members' Choice and no gap networks, which accounted for about A$250.5 million, and Live Better rewards of about A$48.6 million. It also delivered a further A$10 million in productivity savings in FY26. The claims Payout Ratio remained above the industry average, according to the release.
Company Background and Sector Context
Medibank's health offering includes Amplar Health, which supported 5.3 million patient interactions and 4.1 million GP consultations in FY26, according to the release. Medibank Health delivered a record result in the year.
Private health insurance in Australia operates under regulatory settings and competes on premiums, hospital and extras coverage, and provider networks. Household budgets were described in the release as under pressure, which is a Factor for policyholder growth.
Medibank operates in the Australian private health insurance market, with policies sold under its Medibank and ahm brands. The company also runs Medibank Health, which includes Amplar Health's GP and medical clinics. Since launch, the release says the Live Better program has delivered around A$135 million in value, with highly engaged members reporting healthier behaviours. Its claims payout ratio is described in the release as above the industry average.
Risks and Uncertainties
Premium and policyholder growth depend on household budgets, which the company says remain under pressure. Changes in claims costs, regulation or competitive pricing could affect future results.
The release reports growth across several Business lines but does not set out an outlook for policyholder numbers beyond the current year, so the pace of future growth is uncertain.
Policyholder numbers are sensitive to premium changes and competitor offers, and the release describes household budgets as under pressure. The claims payout ratio, which the company says remains above the industry average, can also move with claims experience in later periods.
What to Watch Ahead
Investors will track resident policyholder growth, the claims payout ratio and the progress of Live Better engagement. Updates on the Medibank Health and Amplar Health businesses will also indicate how the group's 2030 ambitions are developing.
Investors will also monitor resident policyholder numbers in the next period and the level of value returned through Members' Choice, no gap networks and Live Better. Growth in Medibank Health and the Amplar Health clinic network will indicate progress against the group's 2030 ambitions.
Taken together, the FY26 release shows higher policyholder numbers, a growing value offering to members and continued productivity savings. The share price has risen over the past year, and the next half-year figures will provide the next measure of the company's progress.






Please wait processing your request...